Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

US Patent 5028422 · Granted Jul 2, 1991

Estimated economic value: $67,002,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Implantable open vein valve2019
Binary exploding target, package process and product2015
Binary exploding target, package process and product2013
Binary exploding target, package process and product2005
Methods for the treatment of infection caused by Hepatitis B virus (HBV)1995
Treatment of squamous cell carcinoma intralesionally with recombinant human alph1993
Treatment of squamous cell carcinoma intralesionally with recombinant human alph1993
Treatment of squamous cell carcinoma intralesionally with recombinant human alph1993
Treatment of actinic keratoses with alpha.sub.2 interferon1991
Treatment of actinic keratoses with alpha.sub.2 interferon1991
Treatment of actinic keratoses with alpha.sub.2 interferon1991
Treatment of genital warts with a combination of liquid nitrogen and recombinant1990